apixaban inr result | Elevated International Normalized Ratio Due to A

Keyword	CPC	PCC	Volume	Score	Length of keyword
apixaban inr result	1.29	1	5660	72	19
apixaban	1.71	0.8	6338	46	8
inr	1.42	1	5441	71	3
result	1.86	0.9	3627	1	6

Keyword	CPC	PCC	Volume	Score
apixaban inr result	0.98	1	2312	82

Search Results related to apixaban inr result on Search Engine

Elevated International Normalized Ratio Due to Apixaban in Patie…
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278791/

DA: 5 PA: 37 MOZ Rank: 98 Up or Down: Up

Elevated International Normalized Ratio Due to Apixaban in Patient With
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278791/

DA: 31 PA: 18 MOZ Rank: 19 Up or Down: Up

Laboratory Monitoring of Direct Oral Anticoagulants (DOACs)
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143174/

WEBApr 21, 2021 · Andexanet alfa is administered as an intravenous bolus of about 400 mg if the timing of the last dose of apixaban ≥ 8 h or about 800 mg if the timing of the last dose of apixaban < 8 h or a dose of >10 mg rivaroxaban or 5 mg apixaban. Author: Claire Dunois DOI: 10.3390/biomedicines9050445 Publish Year: 2021 Publication: Biomedicines. 2021 May; 9(5): 445.

Author: Claire Dunois
DOI: 10.3390/biomedicines9050445
Publish Year: 2021
Publication: Biomedicines. 2021 May; 9(5): 445.

DA: 29 PA: 43 MOZ Rank: 3 Up or Down: Up

Evaluation of the Effect of Apixaban on INR in the Inpatient …
sagepub.com

https://journals.sagepub.com/doi/full/10.1177/1074248419838502

WEBMar 24, 2019 · Of patients whose INR increased by more than 0.3, the median (IQR) change in INR from baseline was 0.5 (0.4:0.6). Apixaban is associated with a notable … Author: Mary P Kovacevic, Kenneth E Lupi, Adrian Wong, James F Gilmore, Rhynn Malloy Publish Year: 2019

Author: Mary P Kovacevic, Kenneth E Lupi, Adrian Wong, James F Gilmore, Rhynn Malloy
Publish Year: 2019

DA: 28 PA: 81 MOZ Rank: 8 Up or Down: Up

Practical management of patients on apixaban: a consensus guide
biomedcentral.com

https://thrombosisjournal.biomedcentral.com/articles/10.1186/1477-9560-11-27

WEBDec 31, 2013 · When switching anticoagulation from warfarin to apixaban, it is important to avoid using both drugs at therapeutic doses simultaneously; it is recommended that the …

DA: 60 PA: 90 MOZ Rank: 73 Up or Down: Up

Clinical Monitoring of Direct Acting Oral Anticoagulants
acc.org

https://www.acc.org/latest-in-cardiology/ten-points-to-remember/2017/03/21/13/48/clinical-monitoring-of-direct-acting-oral-anticoagulants

WEBMar 21, 2017 · Despite limited evidence to support that routine renal function monitoring prevents adverse events, the authors of this review recommend assessing renal …

DA: 69 PA: 1 MOZ Rank: 57 Up or Down: Up

Oral Apixaban for the Treatment of Acute Venous …
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa1302507

WEBAug 29, 2013 · Results. The primary efficacy outcome occurred in 59 of 2609 patients (2.3%) in the apixaban group, as compared with 71 of 2635 (2.7%) in the conventional-therapy group (relative risk, 0.84;...

DA: 60 PA: 68 MOZ Rank: 30 Up or Down: Up

Apixaban versus Warfarin in Patients with Atrial Fibrillation
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa1107039

WEBSep 15, 2011 · Results. The median duration of follow-up was 1.8 years. The rate of the primary outcome was 1.27% per year in the apixaban group, as compared with 1.60% …

DA: 19 PA: 79 MOZ Rank: 6 Up or Down: Up

Journal of Cardiovascular Evaluation of the Effect of Apixaban
sagepub.com

https://journals.sagepub.com/doi/pdf/10.1177/1074248419838502

WEBApixaban is associated with a notable increase in INR in hospitalized patients, although it is not clear the clinical impact of the increase.

DA: 75 PA: 41 MOZ Rank: 59 Up or Down: Up